News | June 24, 2024
EMA approves Biocon Biologics’ new mAbs facility in India
Renews GMP certifications for India and Malaysia sites
Renews GMP certifications for India and Malaysia sites
_256_384.jpg)
The company will work closely with the USFDA and is committed to address these comprehensively within stipulated time
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
Department presents a detailed overview of the Pharma and MediTechsector and gives a detailed presentation on the activities of Department
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Azilsartan Medoxomil and Chlorthalidone Tablets had annual sales of US$ 77.9 mn in the United States (IQVIA MAT March 24).
There was no observation related to data integrity reported
Private financing round supported by Fidelity Management & Research Company, T. Rowe Price and Durable Capital Partners
Accelerating sustainability in Indian pharma industry
Subscribe To Our Newsletter & Stay Updated
